Filing Details

Accession Number:
0000899243-21-011578
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-15 16:15:16
Reporting Period:
2021-03-12
Accepted Time:
2021-03-15 16:15:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1466301 Clovis Oncology Inc. CLVS Pharmaceutical Preparations (2834) 900475355
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1834833 C. Thomas Harding C/O Clovis Oncology, Inc.
5500 Flatiron Parkway, Suite 100
Boulder CO 80301
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-03-12 7,367 $5.99 0 No 4 S Direct
Common Stock Disposition 2021-03-12 1,987 $6.00 1,123 No 4 S Indirect By wife
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Indirect By wife